Market Overview

Baird Initiates Coverage on Achillion Pharmaceuticals, Inc. at Outperform, Announces $17.00 PT

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ACHN

DateFirmActionFromTo
Sep 2014UBSMaintainsBuy
Aug 2014Credit SuisseMaintainsNeutral
Aug 2014Deutsche BankUpgradesHoldBuy

View More Analyst Ratings for ACHN
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (ACHN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters